Cargando…
ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies
Aberrant choline metabolism, characterized by an increase in total choline-containing compounds, phosphocholine and phosphatidylcholine (PC), is a metabolic hallmark of carcinogenesis and tumor progression. This aberration arises from alterations in metabolic enzymes that control PC biosynthesis and...
Autores principales: | Gokhale, Samantha, Xie, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234087/ https://www.ncbi.nlm.nih.gov/pubmed/34202989 http://dx.doi.org/10.3390/pharmaceutics13060911 |
Ejemplares similares
-
ChoK-ing the Pathogenic Bacteria: Potential of Human Choline Kinase Inhibitors as Antimicrobial Agents
por: Khalifa, Moad, et al.
Publicado: (2020) -
Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy
por: Chen, Zhihang, et al.
Publicado: (2016) -
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)
por: Schiaffino-Ortega, Santiago, et al.
Publicado: (2016) -
Combined 5-FU and ChoKα Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts
por: de la Cueva, Ana, et al.
Publicado: (2013) -
Genetic Control Of Natural Killing and In Vivo Tumor Elimination by the Chok Locus
por: Idris, Azza H., et al.
Publicado: (1998)